Template:UCSF/Head
From 2010.igem.org
(188 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | {{Template:UCSF/subnav/Hello/BBB/AAA}} | ||
<html> | <html> | ||
+ | |||
+ | <style> | ||
+ | #tocDIV a { | ||
+ | font-size:12px; | ||
+ | color:grey; | ||
+ | } | ||
+ | |||
+ | #tocDIV{ | ||
+ | margin-top:8px; | ||
+ | } | ||
+ | |||
+ | #contentheader{ | ||
+ | color:grey; | ||
+ | text-decoration:none; | ||
+ | font-size: 15px; | ||
+ | cursor:pointer; | ||
+ | } | ||
+ | #innertoc{ | ||
+ | } | ||
+ | |||
+ | .indent{ | ||
+ | text-indent:8px; | ||
+ | font-size:10px; | ||
+ | margin-left:8px; | ||
+ | } | ||
+ | .extraindent{ | ||
+ | text-indent:16px; | ||
+ | font-size:10px; | ||
+ | margin-left:16px; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | |||
+ | <script> | ||
+ | function getElementsByTagNames(list,obj) { | ||
+ | if (!obj) var obj = document; | ||
+ | var tagNames = list.split(','); | ||
+ | var resultArray = new Array(); | ||
+ | for (var i=0;i<tagNames.length;i++) { | ||
+ | var tags = obj.getElementsByTagName(tagNames[i]); | ||
+ | for (var j=0;j<tags.length;j++) { | ||
+ | resultArray.push(tags[j]); | ||
+ | } | ||
+ | } | ||
+ | var testNode = resultArray[0]; | ||
+ | if (!testNode) return []; | ||
+ | if (testNode.sourceIndex) { | ||
+ | resultArray.sort(function (a,b) { | ||
+ | return a.sourceIndex - b.sourceIndex; | ||
+ | }); | ||
+ | } | ||
+ | else if (testNode.compareDocumentPosition) { | ||
+ | resultArray.sort(function (a,b) { | ||
+ | if(a.compareDocumentPosition(b)==4||a.compareDocumentPosition(b)==20){return -1;} | ||
+ | else {return 1;} | ||
+ | }); | ||
+ | } | ||
+ | return resultArray; | ||
+ | } | ||
+ | |||
+ | function createTOC() { | ||
+ | var y = document.createElement('div'); | ||
+ | y.id = 'innertoc'; | ||
+ | var a = document.createElement('a'); | ||
+ | a.innerHTML="<b>Page Content -</b>"; | ||
+ | a.id = 'contentheader'; | ||
+ | a.onclick = showhideTOC; | ||
+ | y.appendChild(a); | ||
+ | var z = y.appendChild(document.createElement('div')); | ||
+ | z.id='tocDIV'; | ||
+ | var bodycon = document.getElementById('Main'); | ||
+ | var toBeTOCced = getElementsByTagNames('h3,h4,h5',bodycon); | ||
+ | if (toBeTOCced.length < 2) return false; | ||
+ | |||
+ | for (var i=0;i<toBeTOCced.length;i++) { | ||
+ | var tmp = document.createElement('a'); | ||
+ | var reg = /<b>([^<]+)<\/b>/; | ||
+ | var str = toBeTOCced[i].innerHTML; | ||
+ | var result = reg.exec(str); | ||
+ | tmp.innerHTML = result[1]; | ||
+ | tmp.className = 'page'; | ||
+ | z.appendChild(tmp); | ||
+ | z.appendChild(document.createElement('br')); | ||
+ | if (toBeTOCced[i].nodeName == 'H4') | ||
+ | tmp.className += ' indent'; | ||
+ | if (toBeTOCced[i].nodeName == 'H5') | ||
+ | tmp.className += ' extraindent'; | ||
+ | var headerId = result[1]; | ||
+ | tmp.href = '#' + headerId; | ||
+ | toBeTOCced[i].id = headerId; | ||
+ | if (toBeTOCced[i].nodeName == 'H2') { | ||
+ | tmp.innerHTML = 'Top'; | ||
+ | tmp.href = '#top'; | ||
+ | toBeTOCced[i].id = 'top'; | ||
+ | } | ||
+ | } | ||
+ | return y; | ||
+ | } | ||
+ | |||
+ | var TOCstate = 'block'; | ||
+ | |||
+ | function showhideTOC() { | ||
+ | TOCstate = (TOCstate == 'none') ? 'block' : 'none'; | ||
+ | var newText = (TOCstate == 'none') ? 'Page Content +' : 'Page Content -'; | ||
+ | document.getElementById('contentheader').innerHTML = '<strong>'+newText+'</strong>'; | ||
+ | document.getElementById('innertoc').lastChild.style.display = TOCstate; | ||
+ | } | ||
+ | |||
+ | </script> | ||
+ | |||
<style> | <style> | ||
Line 8: | Line 119: | ||
#content{ | #content{ | ||
padding-right:10px; | padding-right:10px; | ||
- | |||
- | |||
} | } | ||
Line 28: | Line 137: | ||
h3{ | h3{ | ||
- | + | ||
text-vertical-align:middle; | text-vertical-align:middle; | ||
background-image:url(https://static.igem.org/mediawiki/2010/3/31/UCSF_meihuabiao.png); | background-image:url(https://static.igem.org/mediawiki/2010/3/31/UCSF_meihuabiao.png); | ||
text-indent: 35px; | text-indent: 35px; | ||
background-repeat: no-repeat; | background-repeat: no-repeat; | ||
+ | } | ||
+ | |||
+ | h4{ | ||
+ | color: #467f4a; | ||
+ | text-indent: 35px; | ||
} | } | ||
Line 118: | Line 232: | ||
#navigation { | #navigation { | ||
position: relative; | position: relative; | ||
- | |||
//left: 50%; | //left: 50%; | ||
top: 5px; | top: 5px; | ||
Line 244: | Line 357: | ||
</script> | </script> | ||
- | + | <div style="float:left;width:710px;margin-top:5px; | |
- | + | background-image: url(http://gaips.inesc-id.pt/aamas2008/images/banner.jpg); | |
- | + | background-repeat:no-repeat;" id="Main"> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | <div style="float:left;width: | + | |
<div id="navigation"> | <div id="navigation"> | ||
<ul> | <ul> | ||
Line 261: | Line 365: | ||
<li class="active"><a href="https://2010.igem.org/Team:UCSF">Home</a></li> | <li class="active"><a href="https://2010.igem.org/Team:UCSF">Home</a></li> | ||
- | <li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Team">Team</a><ul> | + | <li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Team">Team</a> |
- | + | <ul> | |
- | <li class="cat-item | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Team/Students" title="">Students</a></li> |
- | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Team/Buddies" title="">Buddies</a></li> | |
- | <li class="cat-item | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Team/Advisors" title="">Advisors</a></li> |
- | <li class="cat-item | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Team/Team_Profile" title="">Team Profile</a></li> |
- | <li class="cat-item cat-item | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Team/Blogs" title="">Blogs</a></li> |
</ul></li> | </ul></li> | ||
<li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Project">Project</a><ul> | <li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Project">Project</a><ul> | ||
- | <li class="cat-item cat-item-68"><a href="https://2010.igem.org/Team:UCSF/Project/ | + | <li class="cat-item cat-item-68"><a href="https://2010.igem.org/Team:UCSF/Project/Abstract" title="">Overview</a></li> |
- | <li class="cat-item cat-item-28"><a href="https://2010.igem.org/Team:UCSF/Project/ | + | <li class="cat-item cat-item-28"><a href="https://2010.igem.org/Team:UCSF/Project/Background_Info" title="">Background Info</a></li> |
- | <li class="cat-item cat-item-364"><a href="https://2010.igem.org/Team:UCSF/Project/ | + | <li class="cat-item cat-item-364"><a href="https://2010.igem.org/Team:UCSF/Project/Project_Aims" title="">Project Aims</a></li> |
- | <li class="cat-item | + | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/Project/Future_Implications" title="">Future Implications</a></li> |
+ | <li class="cat-item"><a href="https://2010.igem.org/Team:UCSF/References">References</a></li> | ||
</ul></li> | </ul></li> | ||
+ | |||
+ | |||
+ | <li class="not-active"><a href="https://2010.igem.org/Team:UCSF/Protocols">Protocols</a></li> | ||
+ | |||
+ | <li class="not-active"><a href="https://2010.igem.org/Team:UCSF/Parts">Parts</a></li> | ||
+ | |||
+ | <li class="not-active"><a href="https://2010.igem.org/Team:UCSF/Gold_and_Silver_Medal_Requisite">Judging Form</a></li> | ||
<li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Notebook">Notebook</a><ul> | <li class="not-active sub-nav"><a href="https://2010.igem.org/Team:UCSF/Notebook">Notebook</a><ul> | ||
Line 292: | Line 404: | ||
</ul></li> | </ul></li> | ||
- | |||
- | <li class="not-active | + | <li class="not-active"><a href="http://mac.appstorm.net/category/general/">Safety</a></li> |
- | </li> | + | <li class="not-active"><a href="http://mac.appstorm.net/about/">Human Practice</a></li> |
- | + | <li class="not-active"><a href="http://mac.appstorm.net/about/">Gallery</a></li> | |
- | + | <!--<li class="right"><script>writeHref();</script>Edit</a></li>--> | |
- | + | <!--<li class="right"><a href="https://igem.org/Login">Log in</a></li>--> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | <li class="not-active"><a href="http://mac.appstorm.net/about/"> | + | |
- | <li class="not-active"><a href="http://mac.appstorm.net/about/"> | + | |
- | <li class="right"><script>writeHref();</script>Edit</a></li> | + | |
- | <li class="right"><a href="https://igem.org/Login">Log in</a></li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
+ | |||
+ | <div id="breadcrumbs"> | ||
+ | <nav> | ||
+ | <ul id="sub-navigation"> | ||
+ | <li class="first parent parent-1"><a href="https://2010.igem.org/Team:UCSF">Home</a></li> | ||
+ | </ul> | ||
+ | </nav> | ||
+ | </div> | ||
+ | <script>getLadder();</script> | ||
+ | |||
+ | <div style="background-color: #ede8e2;margin-top:160px;"> | ||
</html> | </html> | ||
Line 324: | Line 431: | ||
Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients. | Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients. | ||
+ | ===='''Project1'''==== | ||
+ | ==='''Home'''=== | ||
+ | ==='''TOC'''=== | ||
+ | ==='''Hello'''=== | ||
<html> | <html> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="float:right;width:250px;margin-top:-5px;"> | ||
+ | <div style="width:250px;background-color:#FF330D;margin-top:0px;-moz-border-radius: 8px; | ||
+ | -webkit-border-radius: 8px; | ||
+ | border-radius: 8px;"> | ||
+ | <form action="https://2010.igem.org/Team:UCSF/Search" id="cse-search-box" style="margin-top:8px;margin-left:8px;margin-right:auto;padding-top:8px;"> | ||
+ | <div> | ||
+ | <input type="hidden" name="cx" value="003596668401458118461:zap8jgrah-m" /> | ||
+ | <input type="hidden" name="cof" value="FORID:10" /> | ||
+ | <input type="hidden" name="ie" value="UTF-8" /> | ||
+ | <input type="text" name="q" size="21" /> | ||
+ | <input type="submit" name="sa" value="Search" size="8"/> | ||
</div> | </div> | ||
+ | </form> | ||
+ | <script type="text/javascript" src="http://www.google.com/cse/brand?form=cse-search-box&lang=en"></script> | ||
- | <div style=" | + | |
- | + | <div style="position:relative;margin-top:10px;width:196px;margin-left:auto;margin-right:auto;padding-bottom:8px;"> | |
<!--<img src="https://static.igem.org/mediawiki/igem.org/9/9a/Natural_Killer.jpg" width="196"/>--> | <!--<img src="https://static.igem.org/mediawiki/igem.org/9/9a/Natural_Killer.jpg" width="196"/>--> | ||
<img src="https://static.igem.org/mediawiki/2010/e/ef/UCSF_2010_Transparent_NK.png" width="196"/> | <img src="https://static.igem.org/mediawiki/2010/e/ef/UCSF_2010_Transparent_NK.png" width="196"/> | ||
</div> | </div> | ||
- | |||
+ | </div> | ||
+ | <div style="position:relative;height:auto;margin-top:8px;padding:10px;border:1px grey dashed;" id="TOCC"> | ||
</div> | </div> | ||
- | </ | + | </div> |
- | + | ||
- | </ | + | |
+ | <script> | ||
+ | function makeTOC(){ | ||
+ | var toc=createTOC(); | ||
+ | var tocdiv=document.getElementById('TOCC'); | ||
+ | tocdiv.appendChild(toc); | ||
+ | } | ||
+ | makeTOC(); | ||
+ | </script> | ||
+ | |||
</html> | </html> | ||
+ | |||
+ | __NOTOC__ |
Latest revision as of 02:49, 10 October 2010
Project Description
Natural killer (NK) cells of the immune system identify cancer and virally-infected cells and kill them. These potent killers travel throughout the body, recognizing proteins and other molecules on the surface of cells. In order to differentiate between healthy and diseased cells, NK cells use a variety of receptors, which bind to specific ligands at the target cells’ surface. The balance between activating and inhibitory signals will tell the NK cell if the target cell is diseased or healthy, respectively. If the target cell is deemed potentially dangerous, the NK cell grips the target cell tightly and creates an immunological synapse at the site of adhesion. Within this immunological synapse, the NK cell releases cytotoxic granules to kill the target cell without harming any nearby cells allowing for a direct, apoptotic death.
Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients.
Project1
Home
TOC
Hello